The latest research confirms a significant effect of cannabinoids against Crohn's disease, a chronic inflammation of the digestive system that affects 500 thousand people in the US and Canadaalone. Researchers from the Institute of Experimental and Clinical Pharmacology at the Medical University of Graz, Austria, continued the research from a previous study. The study showed the full effect of THC versus Crohn's disease in a test period lasting eight weeks to 10 patients.
Cannabis has been used for many centuries against gastrointestinal disorders but only in the past decade modern research shared its experiments on different types of inflammation and ulcerative colitis. The study done by the University of Graz confirmed, with scientific data, the many testimonies of patients with Crohn's disease who have experimented with cannabis to relieve pain, diarrhea, muscle cramps and hypersecretion caused by this autoimmune disease. This latest research also detects a contribution to restoring the damaged epithelial tissue.
The researchers observe that the Sativa variety is the best suited to the treatment of Crohn's disease and point out that 90% of patients who did not respond to traditional treatments with steroids and IBD, drew instead benefits from THC. The study warns finally that the mechanisms by which cannabis acts on the central and peripheral symptoms of this disease are not fully understood and require further research. However, if your doctor recommends a medical cannabis therapy, know that the best products can be found at Powell House Cannabis Club.